122 related articles for article (PubMed ID: 28902351)
1. Anoctamin5 regulates cell migration and invasion in thyroid cancer.
Chang Z; Cai C; Han D; Gao Y; Li Q; Feng L; Zhang W; Zheng J; Jin J; Zhang H; Wei Q
Int J Oncol; 2017 Oct; 51(4):1311-1319. PubMed ID: 28902351
[TBL] [Abstract][Full Text] [Related]
2. Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2.
Pan R; Lu Q; Ren C; Li H; Zeng F; Tian X; Chen H
Aging (Albany NY); 2021 Jul; 13(13):17316-17327. PubMed ID: 34238763
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer.
Zhang GQ; Jiao Q; Shen CT; Song HJ; Zhang HZ; Qiu ZL; Luo QY
Cancer Sci; 2021 Mar; 112(3):997-1010. PubMed ID: 33247999
[TBL] [Abstract][Full Text] [Related]
4. Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer.
Fukami T; Shiozaki A; Kosuga T; Kudou M; Shimizu H; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Morinaga Y; Konishi E; Otsuji E
World J Gastroenterol; 2022 Aug; 28(32):4649-4667. PubMed ID: 36157935
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
6. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
7. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
Qiu W; Yang Z; Fan Y; Zheng Q
Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
Wang Z; Zhang H; Zhang P; Dong W; He L
Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
[TBL] [Abstract][Full Text] [Related]
9. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
10. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
Miao X; Zhao Y
Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors.
Ferretti E; Tosi E; Po A; Scipioni A; Morisi R; Espinola MS; Russo D; Durante C; Schlumberger M; Screpanti I; Filetti S; Gulino A
J Clin Endocrinol Metab; 2008 Oct; 93(10):4080-7. PubMed ID: 18664540
[TBL] [Abstract][Full Text] [Related]
12. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer.
Ishigaki K; Namba H; Nakashima M; Nakayama T; Mitsutake N; Hayashi T; Maeda S; Ichinose M; Kanematsu T; Yamashita S
J Clin Endocrinol Metab; 2002 Jul; 87(7):3433-40. PubMed ID: 12107263
[TBL] [Abstract][Full Text] [Related]
13. Nav1.6 promotes the progression of human follicular thyroid carcinoma cells via JAK-STAT signaling pathway.
Li H; Liu J; Fan N; Wang H; Thomas AM; Yan Q; Li S; Qin H
Pathol Res Pract; 2022 Aug; 236():153984. PubMed ID: 35753135
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
15. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.
Colamaio M; Calì G; Sarnataro D; Borbone E; Pallante P; Decaussin-Petrucci M; Nitsch L; Croce CM; Battista S; Fusco A
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2168-78. PubMed ID: 22965940
[TBL] [Abstract][Full Text] [Related]
16. Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer.
Jung SN; Kang YE; Lee GH; Liu L; Oh C; Jin YL; Lim MA; Lee K; Oh T; Won HR; Chang JW; Koo BS
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32474599
[TBL] [Abstract][Full Text] [Related]
17. miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4.
Ma W; Zhao X; Liang L; Wang G; Li Y; Miao X; Zhao Y
Oncotarget; 2017 Apr; 8(17):28028-28041. PubMed ID: 28427206
[TBL] [Abstract][Full Text] [Related]
18. Nm23 protein expression in thyroid neoplasms.
Royds JA; Silcocks PB; Rees RC; Stephenson TJ
Pathologica; 1994 Jun; 86(3):240-3. PubMed ID: 7808792
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
20. Anoctamin 5 regulates cell proliferation and migration in pancreatic cancer.
Song HY; Zhou L; Hou XF; Lian H
Int J Clin Exp Pathol; 2019; 12(12):4263-4270. PubMed ID: 31933826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]